Detalles de la búsqueda
1.
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.
Pediatr Infect Dis J
; 28(3): 215-9, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19209098
2.
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.
Pediatr Infect Dis J
; 31(1): 47-52, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21987006
3.
Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy.
AIDS
; 25(5): 643-9, 2011 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21297419
4.
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.
Pediatr Infect Dis J
; 29(5): 391-6, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20431379
Resultados
1 -
4
de 4
1
Próxima >
>>